Supernus Pharmaceuticals (SUPN) Net Margin (2011 - 2026)
Supernus Pharmaceuticals' Net Margin came in at -26.65% for Q2 2026, down 40.24 percentage points from 13.60% a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Net Margin (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Supernus Pharmaceuticals reported Net Margin of -13.94%, down 23.64 percentage points year-over-year; for FY2025, it came in at -5.36%, down 16.52 percentage points from FY2024.
- Net Margin carries a five-year change of -29.76 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was 11.16% in FY2024 (+10.94 pp), 0.22% in FY2023 (-8.88 pp), 9.10% in FY2022 (-0.12 pp) and 9.21% in FY2021 (-15.18 pp).
- The Q2 2026 figure represents the lowest quarterly Net Margin since Q1 2014.
- Year-over-year, Net Margin increased in three of the last seven quarters, with an average year-over-year change of -8.89 percentage points.
- The fastest year-over-year change in Net Margin over five years came in Q3 2024 (a gain of 32.29 percentage points), and the weakest in Q3 2025 (a drop of 45.40 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn | -26.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.65% |
| Dec 31, 2025 | -1.94% |
| Sep 30, 2025 | -23.49% |
| Jun 30, 2025 | 13.60% |
| Mar 31, 2025 | -7.89% |
| Dec 31, 2024 | 8.80% |
| Sep 30, 2024 | 21.91% |
| Jun 30, 2024 | 11.83% |
| Mar 31, 2024 | 0.09% |
| Dec 31, 2023 | 0.72% |
| Sep 30, 2023 | -10.38% |
| Jun 30, 2023 | -0.61% |
| Mar 31, 2023 | 11.02% |
| Dec 31, 2022 | 15.23% |
| Sep 30, 2022 | 0.99% |
| Jun 30, 2022 | 4.63% |
| Mar 31, 2022 | 16.80% |
| Dec 31, 2021 | 1.54% |
| Sep 30, 2021 | 14.52% |
| Jun 30, 2021 | 16.79% |
API Access
Supernus Pharmaceuticals Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();